The extent of mediastinal lymph node dissection correlates with survival of small cell lung cancer patients after resection: a propensity score-matched cohort study analysis

被引:3
作者
Cao, Jinlin [1 ]
Xu, Jinming [1 ]
Yu, Haojie [2 ]
Qian, Pengxu [3 ,4 ]
Lv, Wang [1 ]
He, Tianyu [1 ]
Yuan, Ping [5 ]
Longo, Filippo [6 ]
Bertolaccini, Luca [7 ]
Yasufuku, Kazuhiro [8 ]
Rucker, A. Justin [9 ]
Hu, Jian [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Thorac Surg, 79 Qingchun Rd, Hangzhou 310003, Peoples R China
[2] Zhejiang Univ, Coll Chem & Biol Engn, State Key Lab Chem Engn, Hangzhou, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Sch Med, Hangzhou, Peoples R China
[4] Zhejiang Univ, Liangzhu Lab, Med Ctr, Hangzhou, Peoples R China
[5] Zhengzhou Univ, Dept Thorac Surg, Affiliated Hosp 1, Zhengzhou, Peoples R China
[6] Univ Campus Biomed Roma, Dept Thorac Surg, Dept Fac Med & Surg, Rome, Italy
[7] IEO European Inst Oncol IRCCS, Dept Thorac Surg, Milan, Italy
[8] Univ Hlth Network, Toronto Gen Hosp, Div Thorac Surg, Toronto, ON, Canada
[9] Duke Univ, Med Ctr, Dept Surg, Div Cardiovasc & Thorac Surg, Durham, NC 27710 USA
关键词
Small cell lung cancer (SCLC); surgical resection; lymphadenectomy; prognosis; survival; STAGE-I; SURGICAL RESECTION; NUMBER; SURGERY; IMPACT; RADIOTHERAPY; CARCINOMA; TRIAL;
D O I
10.21037/tlcr-22-489
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Evidence on the importance of lymph node (LN) dissection during resection for small cell lung cancer (SCLC) is scarce. This study sought to investigate the clinical impact of the extent of lymphadenectomy on the survival of patients with SCLC. Methods: Patients who underwent resection for primary SCLC between 2000 and 2016 were identified from the Surveillance, Epidemiology, and End Results (SEER) cancer registry. The patients were stratified based on the number of LNs dissected (0, 1-3, 4-11, and >= 12) via an X-Tile software analysis, and lung cancer-specific survival (LCSS) and overall survival (OS) were compared between these stratified groups using Kaplan-Meier curves. A propensity score-matched analysis and a Cox regression model were used to adjust for potential confounders. Results: A total of 1,883 patients with SCLC met our criteria and were enrolled in the study. The LCSS and OS analyses revealed that patients who underwent IN dissection during surgery had longer survival times significantly than patients who did not. Similarly, patients who underwent more extensive LN dissection (>= 14 LNs) had longer survival times than those who underwent less extensive LN dissection (1-3 LNs). However, no significant increase in survival time was found for patients who underwent the dissection of >= 12 LNs compared to those who underwent the dissection of 4-11 LNs. These results were confirmed in our propensity-matched and Cox regression analyses. Conclusions: Our study revealed that patient survival after surgical resection for SCLC is associated with the number of dissected LNs, and the number of LNs for dissection ranges from 4 to 11 achieve the best survival outcome.
引用
收藏
页码:1453 / +
页数:23
相关论文
共 36 条
  • [1] Results of the Two Incidence Screenings in the National Lung Screening Trial
    Aberle, Denise R.
    DeMello, Sarah
    Berg, Christine D.
    Black, William C.
    Brewer, Brenda
    Church, Timothy R.
    Clingan, Kathy L.
    Duan, Fenghai
    Fagerstrom, Richard M.
    Gareen, Ilana F.
    Gatsonis, Constantine A.
    Gierada, David S.
    Jain, Amanda
    Jones, Gordon C.
    Mahon, Irene
    Marcus, Pamela M.
    Rathmell, Joshua M.
    Sicks, JoRean
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (10) : 920 - 931
  • [2] [Anonymous], Clinical Practice Guidelines in Oncology, Inc
  • [3] Immunotherapy in lung cancer: the chemotherapy conundrum
    Buddharaju, Laxmi Narayana R.
    Ganti, Apar Kishor
    [J]. CHINESE CLINICAL ONCOLOGY, 2020, 9 (04)
  • [4] X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
    Camp, RL
    Dolled-Filhart, M
    Rimm, DL
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (21) : 7252 - 7259
  • [5] Prognostic impact of lymphadenectomy on outcomes of sublobar resection for stage IA non-small cell lung cancer ≤2 cm
    Cao, Jinlin
    Xu, Jinming
    He, Zhehao
    Yuan, Ping
    Huang, Sha
    Lv, Wang
    Hu, Jian
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 156 (02) : 796 - +
  • [6] Sealing of the mediastinum with a local hemostyptic agent reduces chest tube duration after complete mediastinal lymph node dissection for stage I and II non-small cell lung carcinoma
    Czerny, M
    Fleck, T
    Salat, A
    Zimpfer, D
    Klepetko, W
    Wolner, E
    Mueller, MR
    [J]. ANNALS OF THORACIC SURGERY, 2004, 77 (03) : 1028 - 1032
  • [7] Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?
    Doddoli, C
    Aragon, A
    Barlesi, F
    Chetaille, B
    Robitail, S
    Giudicelli, R
    Fuentes, P
    Thomas, P
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2005, 27 (04) : 680 - 685
  • [8] FOX W, 1973, LANCET, V2, P63
  • [9] Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Frueh, M.
    De Ruysscher, D.
    Popat, S.
    Crino, L.
    Peters, S.
    Felip, E.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 : 99 - 105
  • [10] Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer
    Gajra, A
    Newman, N
    Gamble, GP
    Kohman, LJ
    Graziano, SL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) : 1029 - 1034